AUTOIMMUNE ENCEPHALITIS (AE)
Clinical trials for AUTOIMMUNE ENCEPHALITIS (AE) explained in plain language.
Never miss a new study
Get alerted when new AUTOIMMUNE ENCEPHALITIS (AE) trials appear
Sign up with your email to follow new studies for AUTOIMMUNE ENCEPHALITIS (AE), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Engineered immune cells take aim at debilitating brain and nerve diseases
Disease control Recruiting nowThis early-phase study is testing a new treatment called universal CAR-T cells (RD06-05) in up to 36 adults with relapsing or refractory multiple sclerosis, myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, or autoimmune encephalitis. The therapy uses speciall…
Matched conditions: AUTOIMMUNE ENCEPHALITIS (AE)
Phase: EARLY_PHASE1 • Sponsor: Tongji Hospital • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
Experimental cell therapy targets tough autoimmune conditions
Disease control Recruiting nowThis early-stage study tests a new cell therapy called QH103 in up to 6 people with relapsed or hard-to-treat autoimmune diseases like multiple sclerosis and myasthenia gravis. The therapy uses specially engineered immune cells to target and calm the overactive immune system. The…
Matched conditions: AUTOIMMUNE ENCEPHALITIS (AE)
Phase: PHASE1 • Sponsor: Tongji Hospital • Aim: Disease control
Last updated May 22, 2026 13:55 UTC
-
New imaging technique aims to reveal hidden brain inflammation
Knowledge-focused Recruiting nowThis study is testing whether a special PET scan can detect inflammation in the brain caused by autoimmune encephalitis, a condition where the immune system attacks the brain. Researchers will compare scan results from 40 patients with the condition to those from healthy voluntee…
Matched conditions: AUTOIMMUNE ENCEPHALITIS (AE)
Phase: PHASE2 • Sponsor: University Hospital, Toulouse • Aim: Knowledge-focused
Last updated May 22, 2026 13:53 UTC